Dr. Pradeep Katwal presented on adult immunization. He discussed how vaccines have led to the eradication of smallpox and near eradication of diseases like diphtheria. He reviewed the immunological basis of vaccines and highlighted various vaccines recommended for adults including influenza, pneumococcal, hepatitis A/B, HPV and herpes zoster vaccines. Adult immunization is important to reduce the burden of vaccine-preventable diseases and protect high risk groups.
Live hepatitis a vaccine - Biovac A - A Long term followup studyGaurav Gupta
Live hepatitis a vaccine - Biovac A - A Long term followup study..
Biovac A, Patiala CME - why Hepatitis A is a problem in India, and why Single dose Live HAV is preferable
adult vaccination, types of vaccine, forms of vaccine, active immunity, passive immunity, schedule of vaccination, CDC, contraindications, cost of vaccines
Immunization is single most important step towards control and elimination of infectious disease.
With regards to epidemiology and population demographics, various changes are made from time to time in Immunization Schedule of the National Health Programme.
This slide show encompasses the recent changes made by National Health Commission with regards to Immunization Schedule.
This presentation aims at helping the pediatric trainees and practitioners to brush up their knowledge in Immunization. The schedule is based on the Universal Immunisation Programme. I have tried to cover as much as possible in terms of individual vaccines and hope it is beneficial to the reader.
Live hepatitis a vaccine - Biovac A - A Long term followup studyGaurav Gupta
Live hepatitis a vaccine - Biovac A - A Long term followup study..
Biovac A, Patiala CME - why Hepatitis A is a problem in India, and why Single dose Live HAV is preferable
adult vaccination, types of vaccine, forms of vaccine, active immunity, passive immunity, schedule of vaccination, CDC, contraindications, cost of vaccines
Immunization is single most important step towards control and elimination of infectious disease.
With regards to epidemiology and population demographics, various changes are made from time to time in Immunization Schedule of the National Health Programme.
This slide show encompasses the recent changes made by National Health Commission with regards to Immunization Schedule.
This presentation aims at helping the pediatric trainees and practitioners to brush up their knowledge in Immunization. The schedule is based on the Universal Immunisation Programme. I have tried to cover as much as possible in terms of individual vaccines and hope it is beneficial to the reader.
Immunization is one of the best public health intervention to reduce mortality and morbidity caused by vaccine preventable diseases. in this part i am going to describe regarding cold chain ,frequently ask questions regarding vaccines and how to manage acute and life threatening adverse reactions at most peripheral level
Immunization is one of the best public health intervention to reduce mortality and morbidity caused by vaccine preventable diseases. in this part i am going to describe regarding cold chain ,frequently ask questions regarding vaccines and how to manage acute and life threatening adverse reactions at most peripheral level
Healthy Mothers Healthy Babies
2014 Annual Meeting & Conference
October 7th, 2014
Presented by: Carol E. Hayes, CNM, MN, MPH
American College of Nurse Midwives representative to CDC Advisory Committee on Immunization Practice (ACIP)
Sharp injuries and needle stick post exposure prophylaxis [compatibility mode]drnahla
Infection Control Guidelines for Sharp injuries and needle stick post exposure prophylaxis
Dr. NAHLA ABDEL KADERوMD, PhD.
INFECTION CONTROL CONSULTANT, MOH
INFECTION CONTROL CBAHI SURVEYOR
Infection Control Director, KKH.
Immunization for INDIAN Adolescents Dr. Jyoti Agarwal Dr. Sharda Jain Dr. J...Lifecare Centre
Vaccinations are among the greatest public health achievements of the 20th century
First recorded in 1890-95
Imminization is the action of making a person immune to infection, typically by inoculation
Immunization prevents disability & death from infectious diseases
It also helps control the spread of infections within communities
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
2. • Jenner was an
English doctor, the
pioneer of smallpox
vaccination and the
father of
immunology….
3. “When meditating over
a disease, I never
think of finding a
remedy for it, but,
instead, a means of
prevention.”
Louis Pasteur
A Vision to future of humanity
3
5. CONDITION ANNUAL NO.
OF
PREVACCINE
CASES
(AVERAGE)
NO. OF CASES
REPORTED IN
2010A
REDUCTION
(%) IN CASES
AFTER
WIDESPREAD
VACCINATION
SMALLPOX 29,005 0 100
DIPHTHERIA 21,053 0 100
INVASIVE
PNEUMOCOCC
AL INFECTION:
<5 YEARS OF
AGE
16,069 4,167C
74
INVASIVE
PNEUMOCOCC
AL INFECTION:
ALL AGES
63,067 44,000C
30
c
Data are from the CDC's Active Bacterial Core Surveillance Report;
www.cdc.gov/abcs/survreports/spneu08.pdf.
Source: Adapted from Roush et al., with permission.
6. • Immunization-
– Immunization is the process whereby a
person is made immune or resistant to an
infectious disease, typically by the
administration of a vaccine.
• Vaccine-
A vaccine is any preparation intended to
produce immunity to a disease by
stimulating the production of antibodies..
11. ADJUVANTS
A vaccine adjuvant is a component that potentiates the
immune responses to an antigen and/or modulates it
towards the desired immune responses.
12. Aims of immunization
• Eradication
– State where disease and its causal agent have been
removed from natural environment
• Elimination
– Reduction to zero cases or reduction in indegineous
sustained transmission of infection in geographical
region.
• Control
– Reduction of illness outcomes and limitation of the
disruptive impacts associated with outbreaks of
disease in communities, schools, and institutions.
13. Why we need adult vaccines ?
Influenza: 10-20% of US population annually
200,000 hospitalizations
36,000 deaths (average)
Burden of Adult Vaccine-Preventable Disease
Pneumococcal: 2,000-5000 meningitis
40,000+ bloodstream infections
150,000-300,000 pneumonia
Pertussis: 1 million
Cervical cancer: 10,000
Shingles: 1 million
Death from vaccine-preventable diseases: 43,000
19. • 2009, update
WHO
199 countries
officially reported
over 482,300
laboratory
confirmed cases of
the influenza H1N1
6,071 deaths
20.
21. • Annual vaccination
• Age 6 months and older
• Early autumn before influenza outbreak
• Influenza A and influenza B
• Influenza type/origin/isolate number/year
of isolation/subtype
22. Live vaccine
• Intranasal via spray
• 2-49 yrs of age
• Non pregnant
• Has currently
– Circulating Strain of influenza A and b
– Cold adapted attenuated master strain
• Protection >90% in young children
• Don’t give antiviral drugs for 2 weeks
23. Killed vaccine
• Inactivated vaccine
• 6 months or older
• Has influenza A and B
– Previous year circulating strain
– Anticipated strain circulating this year
• Immunocompromised
• Protection 50-80% is expected.**
25. • Vaccine was found to be 33% effective in preventing
total respiratory illness (influenza-like illness and
clinically diagnosed pneumonia). In prevention of
pneumonia alone, vaccine was 43% effective. The
estimate for prevention of pneumonia rose to 55% if the
period under consideration was limited to the time of
peak influenza activity. Given the number of eligible
homes and the cohort methodology used, the results
support continuation of current policy, encouraging use
of vaccine in all nursing home residents.
30. Polysaccharide vaccine
(PPV 23)
•CONFLIICTING RESULTS
T Cell independent
immunity
Revaccinate after 5 yrs
Polysaccharide-protein
conjugate vaccine
• The Difference
• Infants and young
• 7,10,13 serotype
– Invasive pneumococcal
vaccine
– Antibiotic resistant strain
31. Harrison figure
Changes in invasive pneumococcal disease (IPD) incidence, by serotype group,
among children <5 years old (first) and adults >65 years old (second), 1998–2007.
*7-Valent pneumococcal conjugate vaccine (PCV7) was introduced in the United
States for routine administration to infants and young children during the second half
of 2000. (Reprinted with permission from Pilishvili et al, 2010.)
32. Conclusion
The recent introduction of universal PCV vaccination in children has led
to a change in the epidemiology of IPD in adults. The incidence of IPD
associated with PCV serotypes is expected to decrease and that
associated with other serotypes is expected to increase in adults.
Despite a reduction in the incidence of IPD, vaccinating the elderly and
at-risk adults with PPV23 in Germany against IPD and NBPP remains a
cost-effective strategy because of its broad serotype coverage.
35. BEHAVIOURAL
Sexually active person without long-term non-
monogamous relationship
Person with more than one sexual partner during six
months
Seeking STI evaluation
Current or recent IV drug user
OCCUPATIONAL
Healthcare professionals risk of exposure to
blood or potentially infectious body fluids
36. Post-exposure prophylaxis
• Included in EPI schedule
• 3 IM injections (deltoid, not
gluteal)
• 0,1,6 months
• Contains HBsAg (10 mcg)
Pre-exposure prophylaxis
• Administer both HBIG and HB vaccine
38. Hepatitis A virus
• Behavioral:
– Men who have sex with men
– IV drugs users
• Occupational:
– Persons working with HAV-infected primates or
with HAV in a research laboratory setting.
• Medical:
– Persons with chronic liver disease
– persons who receive clotting factor concentrates.
• Other:
– Persons traveling to or working in countries that
have high or intermediate endemicity of hepatitis A
39. • Approved by the FDA in United States for
persons >18 years old
• Contains 720 EL.U. hepatitis A antigen and
20 μg. HBsAg
• Vaccination schedule: 0,1,6 months
• Immunogenicity similar to single-antigen
vaccines given separately
• Can be used in persons > 18 years old who
need vaccination against both hepatitis A and
B
• Formulation for children available in many
other countries
COMBINED HEPATITIS A
HEPATITIS B VACCINE
42. • Serogroups A,C,Y W135
T cell independent
Cannot be given in age less than 2 years of age
Efficay C component >90% (children)
Efficacy A component >95%(all age group)
Duration of protection 2-5 yrs
44. MMR
• All adults born in 1957 or later should
have documentation of 1 or more MMR
vaccine
• 2nd
dose- 28 days after first dose
• Previous diagnosis of
– Meseals
– Mumps
– Rubella
45. MESEALS MUMPS RUBELLA
OUTBREAK SETTING OUTBREAK SETTING CHILD BEARING AGE
Students of post-
secondary school
Students of post
secondary school
-If Non-pregnant
-IF immune status is
not known
Upon completion and
before discharge
Healthcare facility
workers
Healthcare facility
workers
International travellers International travellers
46. Human papilloma virus
• Primary goal is to prevent cervical cancer
• All females 11-12 yrs
• Catchup vaccination 13-26 yrs
• Before sexual activity
• Schedule- [0-15days-6 months}
• Quadrivalent (HPV4) vaccine or bivalent
vaccine (HPV2)
• May be administered to males aged 9
through 26 years
47. • Four strains of human papillomavirus
(HPV) -- HPV-6, 11, 16, and 18
49. Tetanus,Diphtheria & acellular Pertusis
• Primary series : 3 dose
1st
& 2nd
dose : at least 4 wks apart
3rd
dose: 6-12 months after the second.
Tdap can substitute any one of the 3 doses of Td
• Booster dose : every 10 yrs
Tdap or Td may be used.
• Tdap should replace single dose of Td in adult aged < 65
yrs.
• Pregnancy:
If last Td vaccine >10 yrs : Td at 2nd
or 3rd
trimester.
If last Td vaccine <10 yrs : Td at immediate post partum
period.
50. Varicella vaccination
• All adults without evidence of immunity
2 doses of single-antigen varicella vaccine
A second dose if received only 1 dose
Special consideration
1) close contact with persons at high risk for severe
disease
2)Person with high risk for exposure or transmission.
52. Herpes zooster
• Single dose
• Adults aged 60 years and older
• Regardless of whether they report a
previous episode of herpes zoster
Hib vaccine
1 dose of Hib vaccine should be considered for
persons who have sickle cell disease, leukemia, or HIV
infection, or who have had a splenectomy
54. REFRENCES
• Harrison's Principles of Internal Medicine,
18th Edition
• Guyton and Hall Textbook of Medical
Physiology (12th Edn)
• http://www.cdc.gov/vaccines/default.htm
• http://www.fda.gov/BiologicsBloodVaccines
/Vaccines/QuestionsaboutVaccines/ucm070
418.htm
Editor's Notes
Twinrix® is a combined hepatitis A and hepatitis B vaccine approved in 2001 by the Food and Drug Administration (FDA) for persons 18 years of age or older. Twinrix® contains 720 EL.U. of hepatitis A antigen and 20 μg of hepatitis B surface antigen.
Primary immunization consists of three doses, given on a 0-, 1-, and 6-month schedule, the same schedule as that used for single-antigen hepatitis B vaccine. Immunogenicity of the combined vaccine appears to be similar to that of the single-antigen vaccines when given separately.
Twinrix® can be used for immunization of persons 18 years of age or older who have indications for vaccination against both hepatitis A and hepatitis B, such as users of illicit injectable drugs, men who have sex with men, and persons with clotting factor disorders who receive therapeutic blood products. Formulation for children is available in many other countries.
For international travel, hepatitis A vaccine is recommended for travelers to areas of high or intermediate hepatitis A endemicity (see slide 10). Hepatitis B vaccine is recommended for travelers to areas of high or intermediate hepatitis B endemicity who plan to live or work for at least 6 months in highly endemic countries (see slide 9 in hepatitis B slide set at http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/hep_b/slide_9.htm).